SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis

BACKGROUND AND AIM: This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling. METHODS: Totally 243 PC patients were recruited, and they were incorporated into partial remission (PR) group, stable disease (SD) group...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Med (Wars)
Autors principals: Gao, Zhenyuan, Wu, Jisong, Wu, Xiao, Zheng, Jialei, Ou, Yimei
Format: Artigo
Idioma:Inglês
Publicat: De Gruyter 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7718643/
https://ncbi.nlm.nih.gov/pubmed/33336063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2020-0157
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars